David Robert Fermin MD FACC, FHFSA
Echocardiography, Heart Failure & Transplantation, Cardiovascular Disease Genetics, Cardiac Critical Care
Medical Director - Hypertrophic Cardiomyopathy Program Advanced Heart Failure/Transplant/Mechanical Circulatory Support Cardiologist
Join to View Full Profile
2902 Bradford St NEGrand Rapids, MI 49525
Phone+1 616-885-5200
Dr. Fermin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- David Fermin MD, FACC, FHFSA is a cardiologist specializing in Advanced Heart Failure at Corewell Health in Grand Rapids, MI. He completed his M.D. and Internal Medicine training at University of Minnesota Medical School, his Cardiovascular Disease and Advanced Heart Failure fellowships at Mayo Clinic, and has been in practice 11 years. He specializes in heart failure & transplantation, hypertrophic cardiomyopathy, amyloidosis, cardiovascular disease genetics, echocardiography, and mechanical circulatory support.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Advanced Heart Failure and Transplant Cardiology, 2012 - 2013- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Cardiovascular Disease, 2009 - 2012
University of MinnesotaResidency, Internal Medicine, 2006 - 2009- University of Minnesota Medical SchoolClass of 2006
Northwestern UniversityBS, Biomedical Engineering, 1994 - 1998
Publications & Presentations
PubMed
- Long-term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights from VALOR-HCM Trial.Milind Y Desai, Anjali Owens, Sara Saberi, Andrew Wang, Kathy Wolski
Circulation. Genomic and Precision Medicine. 2025-03-31 - Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.Milind Y Desai, Sara Saberi, Jeffrey B Geske, Andrew Wang, Paul Cremer
JACC. Heart Failure. 2025-03-03 - 6 citationsMavacamten-Associated Temporal Changes in Left Atrial Function in Obstructive HCM: Insights From the VALOR-HCM Trial.Milind Y Desai, Yuichiro Okushi, Kathy Wolski, Jeffrey B Geske, Anjali Owens
JACC. Cardiovascular Imaging. 2025-03-01
Press Mentions
Heart Transplant Gives Michigan Man New Outlook on Life Amid COVID PandemicJuly 10th, 2021- 21-Year-Old Survives, Thrives After COVID-19-Era Heart TransplantJune 10th, 2021
‘You’re Going to Be Fine’September 28th, 2019- Join now to see all
Professional Memberships
- Member
- International Society of Heart & Lung TransplantationMember
- Heart Failure Society of AmericaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
